LORI MUDER: Open Payments
NPI 1215443536 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,451 in 128 payments from 25 companies in 2025. Trend: 2023 $1,605 · 2024 $2,056 · 2025 $2,451
Food & beverage: $2,428Education: $23
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 24 | $361 |
| Insmed, Inc. | 19 | $269 |
| Verona Pharma, Inc. | 10 | $218 |
| Regeneron Healthcare Solutions, Inc. | 9 | $204 |
| AstraZeneca Pharmaceuticals LP | 4 | $184 |
| Grifols USA, LLC | 7 | $160 |
| Viatris Specialty LLC | 10 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $136 |
| Merck Sharp & Dohme LLC | 5 | $101 |
| GENZYME CORPORATION | 4 | $83 |
Products named: DUPIXENT, Arikayce, Ohtuvayre, NUCALA, Prolastin-C Liquid, TRELEGY ELLIPTA, YUPELRI, GLASSIA.
Industry payments across FL — which companies pay providers there.
